Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.

Despite several big deals that buoyed the numbers, North America early- and seed-stage investment declined to multiquarter ...

It is the fourth US biotech to go public since the start of this year after Ascentage Pharma, Metsera, and Maze Therapeutics ... with CF as possible. The IPO will fund ongoing phase 1 and future ...

Furthermore, Metsera’s IPO opened 42% higher on the Nasdaq Global Select Market, with several financial firms acting as joint bookrunners for the offering. These developments indicate a strong ...

Furthermore, Metsera’s IPO opened 42% higher on the Nasdaq Global Select Market, with several financial firms acting as joint bookrunners for the offering. These developments indicate a strong ...

Arunaya Organics IPO consists of a fresh issue of 52,60,000 equity shares, aggregating to ₹30.51 crore, and an offer-for-sale (OFS) of 3.48 crore equity shares by the promoters selling shareholder.

Ather Energy IPO: Ather IPO price band has been fixed in the range of ₹304 to ₹321 per equity share of face value of Re 1.(https://www.atherenergy.com/) Ather ...

“I think I have lost track of time and gone back centuries to solve an intricate puzzle or game,” Amma was looking up at the gigantic holes in the ceiling of the caves. Light streamed in ...

Ather Energy IPO DAY 3 Live: Institutional buyers take Indian e-scooter maker Ather’s $352 million IPO past finish line - Reuters Electric scooter maker Ather Energy’s $352 million IPO reached ...

Urban Company has filed for an IPO with Sebi to raise Rs 1,900 crore, including a fresh issue of shares and an offer for sale by existing investors like Accel India and Elevation Capital.